<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00669188</url>
  </required_header>
  <id_info>
    <org_study_id>080122</org_study_id>
    <secondary_id>08-HG-0122</secondary_id>
    <nct_id>NCT00669188</nct_id>
  </id_info>
  <brief_title>Patient Provider Communication and Interaction in a Virtual Clinical Setting</brief_title>
  <official_title>Patient-Provider Communication and Interaction in a Virtual Clinical Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Human Genome Research Institute (NHGRI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Summary:&#xD;
&#xD;
      A few studies have explored factors which influence patient-provider communication in a&#xD;
      controlled setting. However, more information is needed about how different factors affect&#xD;
      communication so that it can be improved.&#xD;
&#xD;
      Third- and fourth-year medical students may be eligible for this study. Participants are&#xD;
      recruited from the Washington, D.C. area.&#xD;
&#xD;
      At the research center, participants will use a virtual reality headset to view a virtual&#xD;
      clinic environment and interact with a virtual patient.&#xD;
&#xD;
      After interacting with the virtual patient, participants will complete a questionnaire about&#xD;
      their experience within the virtual clinic and other research-related information.&#xD;
&#xD;
      The total time for the study visit is 60 minutes.&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
      Third- and fourth-year medical students at least 18 years of age. You may not take part in&#xD;
      the study if you have a history of seizures and/or are pregnant.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will investigate research questions regarding factors influencing patient-provider&#xD;
      communication. Participants will interact with a virtual patient in a virtual clinical&#xD;
      setting.&#xD;
&#xD;
      Third- or fourth-year medical students may be eligible for this study. Participants are&#xD;
      recruited from the Washington, D.C. area.&#xD;
&#xD;
      Study participants will perform one task and complete one set of questions at the study&#xD;
      appointment. The task involves viewing a virtual patient s health information and interacting&#xD;
      with the virtual patient in a virtual environment clinical scenario. While in the virtual&#xD;
      environment, the subject wears a head-mounted video unit that allows him or her to see&#xD;
      elements of the environment. The activities in the virtual environment take about 15 minutes.&#xD;
      The total time for the study is about 60 minutes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 24, 2008</start_date>
  <completion_date type="Actual">July 8, 2020</completion_date>
  <primary_completion_date type="Actual">July 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>treatment recommendations</measure>
    <time_frame>at time of study</time_frame>
    <description>recommendations made for the virtual patient's treatment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">326</enrollment>
  <condition>Healthy Volunteer</condition>
  <arm_group>
    <arm_group_label>Information Type 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>genetic risk information</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Information Type 2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>information absent</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Information absent</intervention_name>
    <description>Information</description>
    <arm_group_label>Information Type 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Information</intervention_name>
    <description>Information</description>
    <arm_group_label>Information Type 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
        Healthy adult volunteers who are third or fourth-year medical students. Both men and women&#xD;
        over age 18 will be eligible for this study (though in practice the age range is likely to&#xD;
        naturally be constrained by the typical age of medical students).&#xD;
&#xD;
        EXCLUSION CRITERIA: 1) persons with seizure or vestibular disorders; 2) women with known&#xD;
        pregnancy; 3) persons who are highly prone to motion sickness; 4) those with low,&#xD;
        uncorrected vision or hearing; 5) all current and past employees and contractors of&#xD;
&#xD;
        NHGRI; and 6) persons who have received information about the study purpose or procedure&#xD;
        from a past participant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Persky, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Human Genome Research Institute (NHGRI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_2008-HG-0122.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <verification_date>October 22, 2021</verification_date>
  <study_first_submitted>April 29, 2008</study_first_submitted>
  <study_first_submitted_qc>April 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2008</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy Volunteer</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

